Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW ...

This was the stock's fourth consecutive day of gains.

Edwards Lifesciences (NYSE:EW) saw its shares rise by 3% following news that competitor Boston Scientific (NYSE:BSX) is ...

Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

This was the stock's second consecutive day of gains.

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

New research by Edwards Lifesciences has demonstrated that early intervention for severe aortic stenosis (AS) before symptoms ...